|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO |
Vidarabine results in increased activity of NR1I2 protein |
CTD |
PMID:25455453 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
ISO |
[Adenosine co-treated with Coformycin] results in decreased expression of FASL mRNA |
CTD |
PMID:11992407 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Gzmb |
granzyme B |
multiple interactions |
ISO |
[Adenosine co-treated with Coformycin] results in decreased expression of GZMB mRNA |
CTD |
PMID:11992407 |
|
NCBI chr15:30,343,361...30,346,792
Ensembl chr15:30,173,603...30,346,814
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[Adenosine co-treated with Coformycin] results in decreased expression of IFNG protein |
CTD |
PMID:11992407 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[Adenosine co-treated with Coformycin] results in decreased expression of IL2 protein |
CTD |
PMID:11992407 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Prf1 |
perforin 1 |
multiple interactions |
ISO |
[Adenosine co-treated with Coformycin] results in decreased expression of PRF1 mRNA |
CTD |
PMID:11992407 |
|
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions |
ISO |
[Adenosine co-treated with Coformycin] results in decreased expression of TNFSF10 mRNA |
CTD |
PMID:11992407 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [cordycepin inhibits the reaction [APP protein modified form results in increased activity of ACHE protein]]; cordycepin inhibits the reaction [APP protein modified form results in increased activity of ACHE protein] |
CTD |
PMID:30031108 |
|
NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Adora2a |
adenosine A2a receptor |
multiple interactions |
EXP |
ADORA2A mutant form inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein]; ADORA2A mutant form inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein]; ADORA2A mutant form inhibits the reaction [cordycepin results in increased phosphorylation of and results in increased expression of TP53 protein] |
CTD |
PMID:24704558 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
EXP |
1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [cordycepin inhibits the reaction [APP protein modified form results in increased activity of ACHE protein]]; cordycepin inhibits the reaction [APP protein modified form results in increased activity of ACHE protein]; cordycepin inhibits the reaction [APP protein modified form results in increased phosphorylation of MAPT protein] |
CTD |
PMID:30031108 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [cordycepin results in increased expression of BAD protein] |
CTD |
PMID:21310227 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions affects localization increases expression |
ISO |
Acetylcysteine inhibits the reaction [cordycepin results in increased expression of BAX protein] cordycepin affects the localization of BAX protein cordycepin results in increased expression of BAX mRNA; cordycepin results in increased expression of BAX protein |
CTD |
PMID:21310227 PMID:21933677 PMID:28987792 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
cordycepin results in decreased expression of BCL2 mRNA; cordycepin results in decreased expression of BCL2 protein Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BCL2 protein] |
CTD |
PMID:21310227 PMID:28987792 PMID:30529626 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BCL2L1 protein] |
CTD |
PMID:21310227 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BID protein] |
CTD |
PMID:21310227 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases expression |
ISO |
Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP3 protein] cordycepin results in increased expression of CASP3 mRNA |
CTD |
PMID:21310227 PMID:21933677 PMID:28987792 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases cleavage |
EXP |
acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein]; ADORA2A mutant form inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein]; pifithrin inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein]; TP53 mutant form inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein]; ZM 241385 inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein] |
CTD |
PMID:24704558 |
|
NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases activity |
ISO |
Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP8 protein] |
CTD |
PMID:21310227 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity increases expression |
ISO |
Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP9 protein] cordycepin results in increased expression of CASP9 mRNA |
CTD |
PMID:21310227 PMID:21933677 PMID:28987792 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases expression |
ISO |
cordycepin results in decreased expression of CAT mRNA |
CTD |
PMID:28987792 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
EXP |
cordycepin inhibits the reaction [Etoposide results in increased expression of CDKN1A mRNA] |
CTD |
PMID:23690541 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
multiple interactions |
EXP |
cordycepin inhibits the reaction [Etoposide results in increased expression of CDKN2A mRNA] |
CTD |
PMID:23690541 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
cordycepin inhibits the reaction [pyridine results in increased expression of CYP3A2 mRNA] |
CTD |
PMID:11181506 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
multiple interactions |
EXP |
cordycepin inhibits the reaction [pyridine results in increased expression of CYP3A23-3A1 mRNA] |
CTD |
PMID:11181506 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases phosphorylation |
EXP |
cordycepin results in increased phosphorylation of EIF2A protein |
CTD |
PMID:23690541 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases expression |
ISO |
cordycepin results in decreased expression of GPX1 mRNA |
CTD |
PMID:28987792 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
increases expression |
ISO |
cordycepin results in increased expression of MAP1LC3A mRNA |
CTD |
PMID:28987792 |
|
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
EXP |
cordycepin inhibits the reaction [APP protein modified form results in increased phosphorylation of MAPT protein] |
CTD |
PMID:30031108 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
EXP |
acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein]; ADORA2A mutant form inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein]; pifithrin inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein]; TP53 mutant form inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein]; ZM 241385 inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein] |
CTD |
PMID:24704558 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression |
ISO |
cordycepin results in decreased expression of SOD1 mRNA |
CTD |
PMID:28987792 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions |
EXP |
cordycepin inhibits the reaction [Etoposide results in increased activity of SP1 protein]; cordycepin inhibits the reaction [Etoposide results in increased expression of SP1 mRNA] |
CTD |
PMID:23690541 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
EXP ISO |
ADORA2A mutant form inhibits the reaction [cordycepin results in increased phosphorylation of and results in increased expression of TP53 protein]; cordycepin promotes the reaction [Etoposide results in increased expression of TP53 protein]; cordycepin results in increased phosphorylation of and results in increased expression of TP53 protein; TP53 mutant form inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein]; TP53 mutant form inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein]; ZM 241385 inhibits the reaction [cordycepin results in increased phosphorylation of and results in increased expression of TP53 protein] cordycepin results in increased expression of TP53 mRNA |
CTD |
PMID:23690541 PMID:24704558 PMID:28987792 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
decreases expression multiple interactions |
ISO |
cordycepin results in decreased expression of XIAP protein Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of XIAP protein] |
CTD |
PMID:21310227 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases transport increases expression affects response to substance |
ISO EXP |
ABCB1 protein results in increased transport of Puromycin Puromycin results in increased expression of ABCB1A mRNA; Puromycin results in increased expression of ABCB1A protein ABCB1A protein affects the susceptibility to Puromycin |
CTD |
PMID:14675146 PMID:20018165 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression |
ISO |
Puromycin results in increased expression of ABCC1 mRNA |
CTD |
PMID:20018165 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
Puromycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased degradation of AHR protein] Puromycin inhibits the reaction [Omeprazole results in increased expression of AHR protein]; Puromycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHR protein] |
CTD |
PMID:10777561 PMID:25797602 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
multiple interactions |
EXP |
Puromycin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of ALDH3A1 mRNA] |
CTD |
PMID:1953764 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects localization |
ISO |
Puromycin affects the localization of BAX protein |
CTD |
PMID:18339127 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
Puromycin results in decreased expression of BCL2 protein Melatonin promotes the reaction [Puromycin results in decreased expression of BCL2 protein] |
CTD |
PMID:21244482 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions decreases expression |
ISO |
Melatonin promotes the reaction [Puromycin results in decreased expression of BCL2L1 protein] |
CTD |
PMID:21244482 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
Melatonin promotes the reaction [Puromycin results in increased activity of CASP3 protein] |
CTD |
PMID:14502240 PMID:21244482 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Puromycin results in increased activity of CASP9 protein |
CTD |
PMID:14502240 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
ISO |
Puromycin results in decreased expression of CCL2 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
decreases expression |
ISO |
Puromycin results in decreased expression of CCL4 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:68,466,469...68,467,941
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Cd2ap |
CD2-associated protein |
decreases expression |
ISO |
Puromycin results in decreased expression of CD2AP mRNA |
CTD |
PMID:15673299 |
|
NCBI chr 9:18,086,744...18,182,744
Ensembl chr 9:18,086,984...18,182,199
|
|
G |
Cdh3 |
cadherin 3 |
decreases expression |
ISO |
Puromycin results in decreased expression of CDH3 mRNA |
CTD |
PMID:15673299 |
|
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
|
|
G |
Ctnnb1 |
catenin beta 1 |
affects localization |
ISO |
Puromycin affects the localization of CTNNB1 protein |
CTD |
PMID:15673299 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
[Puromycin co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP1A1 mRNA Puromycin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Puromycin results in increased expression of CYP1A1 mRNA |
CTD |
PMID:2985607 PMID:15385644 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Def6 |
DEF6 guanine nucleotide exchange factor |
affects localization |
ISO |
Puromycin affects the localization of DEF6 protein |
CTD |
PMID:22829599 |
|
NCBI chr20:6,268,614...6,290,030
Ensembl chr20:6,268,601...6,289,961
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Puromycin results in increased expression of HMOX1 |
CTD |
PMID:26260164 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il6r |
interleukin 6 receptor |
decreases expression |
ISO |
Puromycin results in decreased expression of IL6R protein modified form |
CTD |
PMID:20116850 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Irf1 |
interferon regulatory factor 1 |
multiple interactions |
ISO |
Puromycin inhibits the reaction [nickel sulfate results in increased expression of IRF1 protein] |
CTD |
PMID:20525893 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Ldlr |
low density lipoprotein receptor |
multiple interactions decreases expression |
ISO |
Puromycin inhibits the reaction [GW 707 results in increased expression of LDLR mRNA]; Puromycin inhibits the reaction [Quercetin results in increased expression of LDLR mRNA]; Puromycin inhibits the reaction [Quercetin results in increased expression of LDLR protein] Puromycin results in decreased expression of LDLR mRNA; Puromycin results in decreased expression of LDLR protein |
CTD |
PMID:12524230 PMID:22388943 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Mir122 |
microRNA 122 |
multiple interactions |
EXP |
Puromycin results in decreased expression of and results in decreased secretion of MIR122 mRNA |
CTD |
PMID:30682439 |
|
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir143 |
microRNA 143 |
multiple interactions |
EXP |
Puromycin results in decreased expression of and results in decreased secretion of MIR143 mRNA |
CTD |
PMID:30682439 |
|
NCBI chr18:55,101,006...55,101,110
Ensembl chr18:55,101,006...55,101,110
|
|
G |
Mir155 |
microRNA 155 |
affects expression |
EXP |
Puromycin affects the expression of MIR155 |
CTD |
PMID:30169741 |
|
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir3473 |
microRNA 3473 |
multiple interactions |
EXP |
Puromycin results in increased expression of and results in increased secretion of MIR3473 mRNA |
CTD |
PMID:30682439 |
|
NCBI chr13:39,499,246...39,499,312
Ensembl chr13:39,499,246...39,499,312
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
Puromycin inhibits the reaction [Dexamethasone affects the localization of NR3C1 protein] |
CTD |
PMID:21569845 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Optn |
optineurin |
multiple interactions |
ISO |
OPTN protein affects the reaction [Puromycin results in increased secretion of VEGFA protein] |
CTD |
PMID:25096716 |
|
NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
multiple interactions |
ISO |
[Puromycin co-treated with PTGS2 protein] results in increased expression of PTGER4 mRNA; [Puromycin co-treated with PTGS2 protein] results in increased expression of PTGER4 protein |
CTD |
PMID:19643929 |
|
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[Puromycin co-treated with PTGS2 protein] results in increased expression of PTGER4 mRNA; [Puromycin co-treated with PTGS2 protein] results in increased expression of PTGER4 protein; [Puromycin co-treated with PTGS2 protein] results in increased expression of TBXA2R mRNA; [Puromycin co-treated with PTGS2 protein] results in increased expression of TBXA2R protein |
CTD |
PMID:19643929 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
multiple interactions |
ISO |
[Puromycin co-treated with PTGS2 protein] results in increased expression of TBXA2R mRNA; [Puromycin co-treated with PTGS2 protein] results in increased expression of TBXA2R protein |
CTD |
PMID:19643929 |
|
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
|
|
G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
multiple interactions |
ISO |
Puromycin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA] |
CTD |
PMID:12147270 |
|
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression multiple interactions increases secretion |
ISO |
Puromycin results in decreased expression of VEGFA protein OPTN protein affects the reaction [Puromycin results in increased secretion of VEGFA protein] |
CTD |
PMID:20116850 PMID:25096716 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|